212 related articles for article (PubMed ID: 12606777)
1. Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
Aldern KA; Ciesla SL; Winegarden KL; Hostetler KY
Mol Pharmacol; 2003 Mar; 63(3):678-81. PubMed ID: 12606777
[TBL] [Abstract][Full Text] [Related]
2. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.
Kern ER; Hartline C; Harden E; Keith K; Rodriguez N; Beadle JR; Hostetler KY
Antimicrob Agents Chemother; 2002 Apr; 46(4):991-5. PubMed ID: 11897580
[TBL] [Abstract][Full Text] [Related]
3. Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney.
Ciesla SL; Trahan J; Wan WB; Beadle JR; Aldern KA; Painter GR; Hostetler KY
Antiviral Res; 2003 Aug; 59(3):163-71. PubMed ID: 12927306
[TBL] [Abstract][Full Text] [Related]
4. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.
Ruiz JC; Beadle JR; Aldern KA; Keith KA; Hartline CB; Kern ER; Hostetler KY
Antiviral Res; 2007 Jul; 75(1):87-90. PubMed ID: 17367874
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine.
Ruiz J; Beadle JR; Buller RM; Schreiwer J; Prichard MN; Keith KA; Lewis KC; Hostetler KY
Bioorg Med Chem; 2011 May; 19(9):2950-8. PubMed ID: 21493074
[TBL] [Abstract][Full Text] [Related]
7. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model.
Buller RM; Owens G; Schriewer J; Melman L; Beadle JR; Hostetler KY
Virology; 2004 Jan; 318(2):474-81. PubMed ID: 14972516
[TBL] [Abstract][Full Text] [Related]
9. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.
Beadle JR; Hartline C; Aldern KA; Rodriguez N; Harden E; Kern ER; Hostetler KY
Antimicrob Agents Chemother; 2002 Aug; 46(8):2381-6. PubMed ID: 12121908
[TBL] [Abstract][Full Text] [Related]
10. Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir.
Kern ER; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Quenelle DC
Antimicrob Agents Chemother; 2004 Sep; 48(9):3516-22. PubMed ID: 15328119
[TBL] [Abstract][Full Text] [Related]
11. Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice.
Hostetler KY; Beadle JR; Trahan J; Aldern KA; Owens G; Schriewer J; Melman L; Buller RM
Antiviral Res; 2007 Mar; 73(3):212-8. PubMed ID: 17123638
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
[TBL] [Abstract][Full Text] [Related]
13. Intraocular safety and pharmacokinetics of hexadecyloxypropyl-cidofovir (HDP-CDV) as a long-lasting intravitreal antiviral drug.
Wang H; Chhablani J; Freeman WR; Beadle JR; Hostetler KY; Hartmann K; Conner L; Aldern KA; Pearson L; Cheng L
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9391-6. PubMed ID: 22058340
[TBL] [Abstract][Full Text] [Related]
14. Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection.
Bidanset DJ; Beadle JR; Wan WB; Hostetler KY; Kern ER
J Infect Dis; 2004 Aug; 190(3):499-503. PubMed ID: 15243923
[TBL] [Abstract][Full Text] [Related]
15. Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.
Ma F; Nan K; Lee S; Beadle JR; Hou H; Freeman WR; Hostetler KY; Cheng L
Eur J Pharm Biopharm; 2015 Jan; 89():271-9. PubMed ID: 25513956
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
Quenelle DC; Collins DJ; Kern ER
Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
[TBL] [Abstract][Full Text] [Related]
17. Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.
Bravo FJ; Bernstein DI; Beadle JR; Hostetler KY; Cardin RD
Antimicrob Agents Chemother; 2011 Jan; 55(1):35-41. PubMed ID: 21078944
[TBL] [Abstract][Full Text] [Related]
18. Intraocular properties of hexadecyloxypropyl-cyclic-cidofovir in Guinea pigs.
Lu S; Cheng L; Hostetler KY; Koh HJ; Beadle JR; Davidson MC; Freeman WR
J Ocul Pharmacol Ther; 2005 Jun; 21(3):205-9. PubMed ID: 15969637
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and early development of hexadecyloxypropylcidofovir: an oral antipoxvirus nucleoside phosphonate.
Hostetler KY
Viruses; 2010 Oct; 2(10):2213-2225. PubMed ID: 21994617
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA.
Dal Pozzo F; Andrei G; Lebeau I; Beadle JR; Hostetler KY; De Clercq E; Snoeck R
Antiviral Res; 2007 Jul; 75(1):52-7. PubMed ID: 17184854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]